Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-19

Clinical Trial Update: Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating safety and tolerability of a herpes zoster vaccine in rheumatologic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Herpes Zoster | Phase 4 | Status: UNKNOWN